Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Financing |
---|---|
6/30/2025 | $ -255K |
3/31/2025 | $ -224K |
12/31/2024 | $ -141K |
9/30/2024 | $ 82.65M |
6/30/2024 | $ 82.61M |
3/31/2024 | $ 82.61M |
12/31/2023 | $ 82.39M |
9/30/2023 | $ -61K |
6/30/2023 | $ -40K |
3/31/2023 | $ -96K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Mar 31, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.22K |
---|---|
min | $ -367.1M |
max | $ 366M |
average | $ -6.84M |
median | $ 305K |
std | $ 119.27M |